Prenetics Global Limited (NASDAQ:PRENW)
| Market Cap | 353.58M-39.1% |
| Revenue (ttm) | 142.56M+167.7% |
| Net Income | -67.61M-35.7% |
| EPS | -4.16-7.5% |
| Shares Out | 15.05M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,970 |
| Open | 0.02 |
| Previous Close | 0.01 |
| Day's Range | 0.01 - 0.02 |
| 52-Week Range | 0.01 - 0.02 |
| Beta | 0.25 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 5, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About PRENW
Prenetics Global Limited operates as an investment holding company specializing in diagnostics and genetic testing. Its core offerings include CircleDNA, a consumer genetic testing solution, and the Circle HealthPod, a rapid detection health monitoring system that enables users to perform point-of-care or at-home COVID-19 tests using nucleic acid amplification technology. The company's portfolio further comprises ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an accessible at-home blood testing kit; and Circle Medical, a diagnostic testing platform. Other products include Circle One, F1x, and Fem. Established in 2014, Prenetics Global Limited is headquartered in Quarry Bay, Hong Kong.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$PRENW stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in PRENW holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by PRENW's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
PRENW Estimated quarterly lobbying spending
Source: U.S. Senate LDA
PRENW Revenue by Segment or Geography
Source: SEC EDGAR (10-Q/10-K)
U.S. Patents
New PRENW patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to PRENW from public contracts
Source: USAspending.gov
PRENW Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from PRENW’s recent data — informational, not investment advice